[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder]
- PMID: 9435799
[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder]
Abstract
Bladder cancers display different forms from superficial to aggressive tumours with muscle invasion. Many studies on this disease have been carried out in order to better understand the molecular mechanisms involved in its progression. Two loci are frequently associated with bladder tumorigenesis. The chromosome 9 lesions seem to be earlier involved in carcinogenesis, and suggest the presence of a tumour suppressor gene, and on the other hand the TP53 gene mutations (17q13.1) are later but take place in tumour progression. These alterations could be used as early diagnosis tool in bladder tumours and orientate the search for the bladder cancer gatekeeper gene(s).
Similar articles
-
Two molecular pathways to transitional cell carcinoma of the bladder.Cancer Res. 1994 Feb 1;54(3):784-8. Cancer Res. 1994. PMID: 8306342
-
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.Oncogene. 1999 Feb 4;18(5):1185-96. doi: 10.1038/sj.onc.1202385. Oncogene. 1999. PMID: 10022124
-
Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.Oncogene. 1997 May 1;14(17):2059-70. doi: 10.1038/sj.onc.1201044. Oncogene. 1997. PMID: 9160886
-
The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.J Urol. 2003 Apr;169(4):1219-28. doi: 10.1097/01.ju.0000056085.58221.80. J Urol. 2003. PMID: 12629332 Review.
-
Alterations of tumor suppressor genes in bladder cancer.Semin Diagn Pathol. 1997 May;14(2):123-32. Semin Diagn Pathol. 1997. PMID: 9179973 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous